Basel Medical Group (NASDAQ:BMGL) Stock Price Crosses Below 50 Day Moving Average – Should You Sell?

Basel Medical Group Ltd (NASDAQ:BMGL – Get Free Report)’s stock price crossed below its fifty day moving average during trading on Tuesday. The stock has a fifty day moving average of $4.30 and traded as low as $1.53. Basel Medical Group shares last traded at $1.93, with a volume of 15,492,087 shares changing hands.

Analysts Set New Price Targets

A number of brokerages recently commented on BMGL. Wall Street Zen upgraded Basel Medical Group to a “hold” rating in a research note on Saturday, November 7th. Weiss Ratings raised Basel Medical Group from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, November 4th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the stock has an average rating of “Sell”.

Read Our Latest Analysis on Basel Medical Group

Basel Medical Group Stock Performance

The firm has a 50-day moving average of $4.12 and a 200 day moving average of $6.26. The company has a debt-to-equity ratio of 0.75, a current ratio of 1.23 and a quick ratio of 1.21.

Basel Medical Group (NASDAQ:BMGL – Get Free Report) last announced its quarterly earnings results on Friday, October 30th. The company reported ($0.31) earnings per share (EPS) for the quarter. The business had revenue of $3.14 million during the quarter.

About Basel Medical Group

(Get Free Report)

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

Further Reading

Receive News & Ratings for Basel Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basel Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.